Search results for: 'virtual diagnostic test landscape'
- Related search terms
- Landscape and Opportunities in the UAE/GCC Boat Market
- test equipment market forecast to 2024
- diagnostics market outlook services
- test equipment market forecast to 2025
- diagnostics market analysi
-
30 Oct 2025  |  Global  |  Technology Research
At-Home Diagnostics Innovations and Growth Opportunities
Transition from Smart Home to Smarter Health At Home Fueling Technology Competition
At-home diagnostics is a rapidly growing field constantly exploring new and innovative solutions to address the challenges of diagnosing broad-spectrum disorders. Recent advancements in emerging at-home diagnostics technologies have attracted significant interest due to their potential to revolutionize the field. This shift has created promising op...
$4,950.00 -
21 Jul 2026  |  Global  |  Market Research
Point-of-Care Testing Market, Global, 2024–2031
The POCT Market is Experiencing Transformational Growth, Driven by Decentralized Molecular Diagnostics, Ultra-rapid Testing, and Connected Clinical Intelligence Ecosystems
The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized treatment, and expanded access to testing across h...
$2,450.00 -
19 Dec 2022  |  North America  |  Market Research
PCR-based PoC Platforms for Infectious Disease Testing Growth Opportunities
Multimodal and Multiplex Platforms are Expanding the Molecular PoC Testing Ecosystem
Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...
$2,450.00
Special Price $1,837.50 save 25 %
-
29 Aug 2025  |  Global  |  Market Research
Oncology Biomarker Diagnostics, Global, 2024–2030
Regulatory Approvals, Companion Diagnostic Partnerships, and Precision Medicine are Driving Transformational Growth in the Industry, Fueled by Advances in Genomic Profiling and AI Integration
This research service offers a comprehensive analysis of the global oncology biomarker diagnostics market, which has transformed with the convergence of clinical demand, advances in technology, and strategic collaborations/partnerships coupled with precision medicine initiatives. It categorizes the market by technology (omics, immunoassays, bioinfo...
$4,950.00 -
13 Dec 2022  |  Global  |  Technology Research
Companion Diagnostics (CDx): Technology Innovation and Growth Opportunities
The Transition to Precision Medicine is Propelling the Adoption of CDx Platforms.
The concept of companion diagnostics (CDx) was developed when researchers realized that even potent drugs only had an efficacy between 25% and 60%, the lowest being in oncology. Therefore, a clinical pharmacogenetic assay became important to distinguish patients more likely to respond to a drug or at a lesser risk of associated adverse pathophysiol...
$4,950.00
Special Price $3,712.50 save 25 %
-
11 Sep 2026  |  Global  |  Market Research
Growth Impact of AI on the Communication Test Equipment Market, 2025–2030
Use of AI for Diagnostics and Predictive Analytics is Driving Transformational Growth
Artificial intelligence (AI) is reshaping the global communication test equipment market by transforming product development, enabling intelligent and automated testing, and driving demand through next-generation communication infrastructure. This Frost & Sullivan analysis examines AI's impact across the communication test equipment value chain, fr...
$2,450.00 -
11 Jan 2021  |  North America  |  Market Research
Increasing Demand for Value-based Care and Acute Shortage of ICU Staff to Drive Growth of the US & EU-5 Virtual Critical Care Solutions Market, 2025
Future Growth Potential to Be Accelerated by Opportunities in Affordable, Easy-to-Deploy, and Scalable Solutions
Coronavirus (COVID-19) has fuelled a demand for solutions that can help cater to large patient populations remotely. Further, the shortage of intensivists, as estimated by the COMPACCS trial, is expected to increase from 22% in 2020 to 35% by 2030. These, as well as changing reimbursement policies, are some of the key trends that will define the fu...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Jan 2025  |  Global  |  Market Research
Global Cardiac Biomarkers Diagnostics Industry, 2024-2029
Rising Prevalence of CVD and High Sensitivity POCT Driving Transformational Growth in Cardiac Biomarkers Diagnostics
The global cardiac biomarkers diagnostics market is forecast to record robust growth with the increased prevalence of cardiovascular disease (CVD), multiplex biomarkers, advancements in diagnostic testing technology, higher POCT adoption rates, and an intensive focus on preventive healthcare. CVDs are a leading cause of mortality globally, highligh...
$4,950.00
Special Price $4,207.50 save 15 %
-
25 Nov 2021  |  Global  |  Market Research
Global Modular Test Equipment Growth Opportunities
A Holistic Approach Involving Hardware, Software, and Aftersales Support is Driving Modular Test Equipment’s Future Growth Potential
The objective of this study is to identify the key trends prevailing in the global modular test equipment market and examine the factors that boost and restrain the growth of the market. The study also discusses the product areas that bolster growth for the forecast period (2021 to 2027). The research provides estimates of the market size and futur...
$4,950.00
Special Price $3,712.50 save 25 %
-
16 Oct 2023  |  Global  |  Frost Radar
Frost Radar™: Predictive Genetic Testing Technologies, 2023
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Predictive genetic testing (PGT) comprises analysis of genes, the whole genome, or exomes to predict the risk of a wide range of disorders. It can have long-term implications in preventive healthcare practices, including delayed onset of disease, treatment management, pharmacogenomics, and general wellness. One outcome of the COVID-19 pandemic has ...
$4,950.00
Special Price $3,712.50 save 25 %